BEFORE THE BELL-Sunesis shares rally after FDA move

Nov 5th, 2009 - Forbes

Related content:

NEW YORK, Nov 5 (Reuters) - Shares of Sunesis Pharmaceuticals rose 45 percent to 55 cents in premarket trading on Thursday, after the company said one of its drugs had received orphan drug designation from the Food and Drug Administration.

(ryan.vlastelica@thomsonreuters.com; Tel: +1 646-223-6014; Reuters Messaging: ryan.vlastelica@reuters.com@reuters.net)

Read the whole story on Forbes or try our Toolbar

blog comments powered by Disqus

Rally in fourth quarter carries No. 3 Alabama past LSU 24-15
Nov 7th, 2009 - USA Today
TUSCALOOSA, Ala. (AP) — No. 3 Alabama picked up another dramatic win and a second straight trip to the SEC championship game. Julio Jones caught a 73-yard touchdown...
British Airways posts $346 million loss in first half of 2009
Nov 6th, 2009 - USA Today
LONDON — British Airways on Friday reported a net loss of 208 million pounds ($346 million) in the six months ending in September as the global economic downturn continued to take its toll on revenues.
FDA warns Web sites not to sell banned flavored cigarettes, thought to appeal to new smokers
Nov 6th, 2009 - Los Angeles Times
RICHMOND, Va. (AP) - The Food and Drug Administration said Friday that it has warned several companies to stop selling banned flavored cigarettes to U.S. consumers online.
GE shares up on analyst upgrade
Nov 6th, 2009 - CNNMoney
* Bernstein Research ups GE to "outperform" * Sees major divestitures over next 2-3 years BOSTON (Reuters) - Shares of General Electric Co rose 2.6 percent Friday after Bernstein Researchraised its rating on the largest U.S...
FDA warns against erectile dysfunction supplement
Nov 6th, 2009 - Los Angeles Times
The Food and Drug Administration is warning consumers that Stiff Nights, a "dietary supplement" used to promote erections, contains an illegal drug and is potentially dangerous. Following a complaint...